Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Targepeutics

Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight cancer and other diseases.Our lead compound, Glioblast-13, is currently nearing Phase I clinical trials for high-grade giloma (brain cancer), and is showing promise against other solid tumors.
Glioblast-13 is a genetically engineered recombinant protien that specifically binds and destroys cancer cells with minimal normal cell damage.


Contact Details:
475 West Governor Road
Hershey
Pennsylvania
17033
United States of America
Tel:(717) 533-7772
Fax:
Email:slutkewitte@targepeutics.com
WWW:

www.targepeutics.com/




Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 216 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: targep | targepeutics | .

Search for more companies in Hershey

Search for more companies in Pennsylvania



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Targepeutics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.